Sean Bundy

Sean Bundy currently serves as the Vice President of Quality and Regulatory Affairs at NeoGenomics Laboratories since November 2022. Prior to this role, Sean held various key positions including Chief Operating Officer and Director of Regulatory & Quality at HepQuant from July 2018 to November 2022, and Vice President of Regulatory and Quality at Precision Biopsy, LLC from July 2016 to July 2018. Significant experience was also gained as Director of Quality and Regulatory at Cochlear from January 2009 to July 2016, where leadership included supervising teams and maintaining quality systems. Earlier roles encompassed Regulatory Affairs Manager and Clinical Studies Manager at Cochlear Americas, as well as Systems Integration Engineer at NetRegulus, Incorporated. Sean Bundy holds an MBA from Edinburgh Business School, a postgraduate diploma in Medical Technology Regulatory Affairs from Cranfield University, and a P.G. Certificate in Clinical Studies Management from the University of Chicago.